Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Genetics|August 1, 2022
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell CarcinomaShengxian Xu, Dongze Liu, Taihao Chang, et al.Translational Andrology and Urology|April 14, 2025
Development and validation of multivariable biopsy-free nomograms to predict clinically significant prostate cancer in patients with prostate-specific antigen levels ≥20 ng/mLMingzhe Chen, Shanqi Guo, Junxin Wang, et al.Frontiers in Oncology|June 30, 2023
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyHongtuan Zhang, Dongze Liu, Zheng Qin, et al.Aging|December 26, 2023
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancerShengxian Xu, Dongze Liu, Zheng Qin, et al.Oxidative Medicine and Cellular Longevity|October 27, 2016
Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In VivoXiong Yang, Hao Ding, Zhenbang Qin, et al.Oncotarget|October 22, 2016
Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egressXingkang Jiang, Changwen Zhang, Shiyong Qi, et al.Iscience|February 25, 2025
Differentiation of high risk prostate cancer with a facile urinary exosome detection workflowShuai Qiu, Yue Li, Zheng Zhang, et al.Translational Andrology and Urology|July 12, 2026
Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort studyBaojun Wang, Dan Xia, Yu Pan, et al.Pageof 4